Schepp, R.M.; Kaczorowska, J.; van Gageldonk, P.G.M.; Rouers, E.D.M.; Sanders, E.A.M.; Bruijning-Verhagen, P.C.J.; Berbers, G.A.M.
Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands. Vaccines 2023, 11, 1807.
https://doi.org/10.3390/vaccines11121807
AMA Style
Schepp RM, Kaczorowska J, van Gageldonk PGM, Rouers EDM, Sanders EAM, Bruijning-Verhagen PCJ, Berbers GAM.
Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands. Vaccines. 2023; 11(12):1807.
https://doi.org/10.3390/vaccines11121807
Chicago/Turabian Style
Schepp, Rutger M., Joanna Kaczorowska, Pieter G. M. van Gageldonk, Elsbeth D. M. Rouers, Elisabeth A. M. Sanders, Patricia C. J. Bruijning-Verhagen, and Guy A. M. Berbers.
2023. "Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands" Vaccines 11, no. 12: 1807.
https://doi.org/10.3390/vaccines11121807
APA Style
Schepp, R. M., Kaczorowska, J., van Gageldonk, P. G. M., Rouers, E. D. M., Sanders, E. A. M., Bruijning-Verhagen, P. C. J., & Berbers, G. A. M.
(2023). Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands. Vaccines, 11(12), 1807.
https://doi.org/10.3390/vaccines11121807
